TCS bets on AI-led growth with Amadeus, ABB partnerships
Indian IT major Tata Consultancy Services (TCS) on Thursday announced two strategic partnerships with Amadeus and ABB, as…
Swiss Roche builds its own AI factory with NVIDIA – with Genentech in California
The planned AI factory will comprise more than 3,500 high-performance GPUs, making it the most powerful setup of…
New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus
Over three quarters of people on Gazyva/Gazyvaro plus standard therapy achieved at least a four-point improvement in SRI-4,…
Is workplace inclusion really that important?
Inclusion is a vital part of our global culture at Novartis, with initiatives led at a country level…
AI safety: Brands need to more than simply comply
Forty eight prestigious brands showcase their creations at the Watches and Wonders annual fair in Geneva – Copyright…
Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol
KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (the “Company” or “Alps Group”), the…
Novartis presents Rhapsido® (remibrutinib) data at AAAAI, showing potential beyond chronic spontaneous urticaria (CSU)
Analyses from REMIX-1 & -2 studies on CSU disease control and early symptom relief will be presented Phase…
Novartis Vanrafia® Phase III data support slowing of kidney function decline in patients with IgA nephropathy
In ALIGN study, Vanrafia (atrasentan) showed positive differencein eGFR change from baseline vs. placebo at Week 136, 4…
5 Key Insights Into How Women Really Feel About Their Breasts
When do conversations around breast health begin? Formally, they often start in grade school, when lessons on puberty…